Anil Potti can add two corrections to his less-and-less impressive publication record. The mega-corrections — part of what we are close to being ready to call a trend in errata notices — in the Journal of Clinical Oncology (JCO) are, however, quite impressive, each with at least a dozen points. One of the corrections, for … Continue reading Two mega-corrections for Anil Potti in the Journal of Clinical Oncology
Authors’ financial disclosures can be a thorny issue for scientific journals. There’s often confusion over just what should be listed as a conflict of interest, and when relationships are revealed after papers are published, lack of disclosure sometimes leads to corrections. For example, the Journal of Cell Science recently published this:
The Journal of Clinical Anesthesia has retracted a paper by a group of Israeli authors whose study may not have had appropriate ethical approval — or even collected the reported data. The article, “Accidental venous and dural puncture during epidural analgesia in obese parturients (BMI > 40 kg/m2): three different body positions during insertion,” was … Continue reading Anesthesia journal editor says “if you blow us off, it will be retracted,” and sticks to his word
Last week, we covered the case of Michael W. Miller, a former department chair at the State University of New York (SUNY) Upstate who was forced to retract a paper in the Journal of Neurochemistry after a university investigation found he had committed misconduct. We figured more retractions might be on the way, so we … Continue reading Second retraction for former SUNY Upstate department chair found guilty of misconduct
The wild and woolly saga of the paper that claims to solve “the puzzle of the origin and evolution of cellular life in the universe” continues. Yesterday, Ivan wrote on his Tumblr about Case Western’s Erik D. Andrulis‘ paper, “Theory of the Origin, Evolution, and Nature of Life:”
Three papers in Current Eye Research have apparently not quite lived up to the journal’s name. The journal in November retracted three studies from a group of authors in China who had previously published the papers in their native language. Here’s the notice, which also appears in this month’s print edition:
In two unrelated cases, the Office of Research Integrity (ORI) has sanctioned a grad student and a pair of colleagues, one of whom plagiarized and the other allowed the intellectual theft to go unchecked. We think the handling of these cases — both first noted briefly by The Chronicle of Higher Education — is worth noting.
In the wake of the massive allegations of fraud by resveratrol researcher Dipak Das, other researchers in the field are clearly trying to distance themselves from the University of Connecticut scientist. Nir Barzilai told us yesterday, for example, that despite Das seemingly’ impressive publication record, “Rome was not built on Dr. Das.” Harvard’s David Sinclair went … Continue reading So how peripheral was Dipak Das’ resveratrol work, really?
The University of Connecticut, in what clearly seems like an attempt to get ahead of damaging news, has announced an “extensive” investigation into research misconduct involving one of its scientists, Dipak K. Das. According to a press release, the university has notified 11 journals that published Das’ work about the alleged fraud. One area of … Continue reading UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case
If there’s one thing worse than having your paper rejected by a journal, it’s having it retracted. But usually a paper has to be accepted before it’s published and withdrawn. Not so for a study from the United Arab Emirates, “Detection and genotyping of GB virus-C in dromedary camels in the United Arab Emirates,” published in 2010 in Veterinary Microbiology. … Continue reading Eye of the needle? Paper about camels gets rejected, then published, then retracted